Log in or Sign up for Free to view tailored content for your specialty!
Chronic Cough News

Parents with chronic cough face increased odds for offspring with cough
The confounder-adjusted likelihood for nonproductive chronic cough in offspring was greater in parents with vs. without this type of cough, according to results published in ERJ Open Research.
21% of patients with chronic cough prescribed opioid-containing cough suppressant

A prescription for an opioid-containing cough suppressant was found in more adults with chronic vs. non-chronic cough, according to results published in Therapeutic Advances in Respiratory Disease.
Multiple comorbidities, triggers associated with chronic cough

WASHINGTON — Asthma was the most common comorbidity associated with chronic cough in the findings of a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Continuous cough monitoring beneficial in chronic cough trial

In a trial evaluating a refractory chronic cough treatment, continuous cough monitoring allowed researchers access to an abundance of data and the treatment’s impact over time, according to a presentation at the Hyfe Cough Science Forum.
Odds elevated for chronic cough in patients with asthma

WASHINGTON — Patients with asthma face heightened odds for chronic cough, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
FDA declines to approve gefapixant for chronic cough a second time

The FDA has issued a complete response letter declining to approve a new drug application for gefapixant as a treatment for adults with refractory or unexplained chronic cough, according to a press release from Merck.
Q&A: AI-developed algorithms could change chronic cough monitoring

In November, all but one of the members of the FDA’s Pulmonary-Allergy Drugs Advisory Committee voted against recommending the approval of gefapixant for adults with refractory or unexplained chronic cough.
FDA panel votes against gefapixant for unexplained chronic cough

In a 12-to-1 vote, the FDA’s Pulmonary-Allergy Drug Advisory Committee voted against approving gefapixant 45 mg tablets to treat adults with refractory or unexplained chronic cough.
Gefapixant yields modest improvements in refractory, unexplained chronic cough vs. placebo

Gefapixant only showed small effects vs. placebo on objective cough frequency, cough severity and quality of life among adults with refractory or unexplained chronic cough, according to results of a systematic review and meta-analysis.
Various causes drive chronic cough in children, prompting different treatment

PARK CITY, Utah — Chronic cough has a variety of causes in children, with broad options for treatment, according to a talk at the Association of PAs in Allergy, Asthma and Immunology Annual Allergy, Asthma & Immunology CME Conference.
-
Headline News
Obesity and diabetes: Understanding the global surge and how to solve it
March 14, 20253 min read -
Headline News
Wood dust exposure negatively impacts lung function in carpenters
March 17, 20253 min read -
Headline News
Exercise improves mental health for women with chronic pelvic pain disorders
March 17, 20252 min read
-
Headline News
Obesity and diabetes: Understanding the global surge and how to solve it
March 14, 20253 min read -
Headline News
Wood dust exposure negatively impacts lung function in carpenters
March 17, 20253 min read -
Headline News
Exercise improves mental health for women with chronic pelvic pain disorders
March 17, 20252 min read